西藏药业 (600211)

Tibet Rhodiola Pharmaceutical Holding Co.

ASH

Tags

MSCI Component StocksSSE 380 IndexBrain-Computer InterfaceInnovative DrugsPharmaceutical ManufacturingPharmaceuticals and HealthcareInfant and Child ConceptBiological ProductsBiological VaccinesHigh-Performing StocksMargin Trading and Securities LendingRestructuring StocksHigh-Dividend Stocks

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 32231.92
  • Circulating A-Shares(W): 32231.92
  • Earnings Per Share(RMB): 2.2400
  • Net Assets Per Share(RMB): 11.0184
  • Operating Revenue(W RMB): 208927.09
  • Total Profit(W RMB): 81045.39
  • **Net Profit Attributable to Parent(W RMB) **: 72177.72
  • Net Profit Growth Rate(%): -8.85
  • Weighted Return on Equity(%): 17.8900
  • Operating Cash Flow Per Share(RMB): 2.2120
  • Undistributed Profit Per Share(RMB): 7.0900
  • Capital Reserve Per Share(RMB): 2.2251

2. Main Business

The main business covers:

  • Production and sales of capsules
  • Production and sales of biological preparations
  • Production and sales of granules, coating agents, etc.

3. Company Basic Information

  • Company Name: Tibet Rhodiola Pharmaceutical Holding Company
  • Listing Date: 1999-07-21
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 93 Beijing Middle Road, Lhasa, Tibet Autonomous Region (Registered Address); No. 3 Guangzhou Road, Zone A, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region; No. 427 Sanse Road, Jinjiang District, Chengdu City, Sichuan Province (Office Address)
  • Website: http://www.xzyy.cn
  • Company Profile: The company was established on July 14, 1999, through a public offering, with Tibet Huaxi Pharmaceutical Group Co., Ltd. as the main sponsor, jointly initiated by four enterprises including Tibet Autonomous Region Tibetan Medicine Factory, Tibet Autonomous Region Science and Technology Development Exchange Center, Tibet Kelong Construction Building Materials Co., Ltd., and Tibet Keguang Solar Energy Engineering Technology Co., Ltd. The sponsors contributed part of their production and operating net assets and cash, converted into 77.60 million state-owned legal person shares. After issuing 45 million public shares on July 1, 1999, the company's total share capital reached 122.60 million shares. Its public shares were listed on the Shanghai Stock Exchange on July 21, 1999.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Tibet Kangzhe Enterprise Management Co., Ltd. General Legal Person 10404.34 32.28
2 Tibet Huaxi Pharmaceutical Group Co., Ltd. General Legal Person 5614.83 17.42
3 Beijing New Phoenix City Real Estate Development Co., Ltd. General Legal Person 1028.30 3.19
4 Shenzhen Kangzhe Pharmaceutical Co., Ltd. General Legal Person 1002.13 3.11
5 Tianjin Kangzhe Pharmaceutical Technology Development Co., Ltd. General Legal Person 633.94 1.97
6 Tibet Science and Technology Innovation Investment Co., Ltd. General Legal Person 619.90 1.92
7 Hong Kong Securities Clearing Company Ltd. Northbound Capital 365.85 1.14
8 Guojin Securities (Hong Kong) Limited - Client Funds (Exchange) General Legal Person 240.89 0.75
9 Yinhua CSI Innovative Drug Industry ETF Fund 158.17 0.49
10 Southern CSI 1000 ETF Fund 147.59 0.46

5. Concept Sectors

  • Biological Vaccines
  • Infant and Child Concept
  • Brain-Computer Interface
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • Blue-chip Stocks
  • MSCI Constituent
  • Restructuring Stocks
  • High Dividend Stocks
  • SSE 380

Remarks

  • Data update date: 2025-11-02
  • Data source: Public Market Information